Ostrum Asset Management Laboratory Corp Of America Holdings Transaction History

Ostrum Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $67,301 - $74,884	322 Added 1.28%	25,405 $5.55 Billion
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $780,084 - $896,886	3,946 Added 18.67%	25,083 $5.7 Billion
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $162,649 - $179,355	809 Added 3.98%	21,137 $4.25 Billion
Q2 2023 Aug 11, 2023	BUY	$211.93 - $241.33 $1.46 Million - $1.67 Million	6,905 Added 51.44%	20,328 $4.91 Billion
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $2.86 Million - $3.46 Million	13,423 New	13,423 $3.08 Billion

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

Stay updated on Ostrum Asset Management with notifications on news.